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256a Monday, February 9, 2015SP-A binds to lipid A more tightly than to DPPC. These results suggest that
SP-A may transfer from surfactant DPPC to pathogen membranes to initiate
its host defense functions.
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Transient binding of amphitropic proteins to membranes can be mediated
by phospholipid cation / tyrosine p interactions. Bacillus thuringiensis
phosphatidylinositol-specific phospholipase C (BtPI-PLC) is a secreted viru-
lence factor that targets GPI-anchored proteins in the outer surface of eukary-
otic plasma membranes, a bilayer rich in choline-containing lipids. BtPI-PLC
has a plethora of tyrosine residues around the surface of the a/b-barrel, and
molecular dynamics (MD) simulations suggest that choline headgroups and
these Tyr residues form short-lived cation-p complexes. To investigate these
interactions, BtPI-PLC was site-specifically spin-labeled and high resolution
field cycling 31P NMR relaxometry was used to quantify the effect of the
spin-labeled BtPI-PLC variants on phosphatidylcholine (PC) and phosphatidyl-
methanol (PMe, used as the surrogate substrate) in small vesicles. The para-
magnetic relaxation enhancement at very low fields (<0.04 T) confirmed the
existence of two moderately long-lived sites for PC binding - one near the
active site and the other on the barrel rim quite removed from the active site.
The distances extracted are consistent with the two major sites of PC binding
suggested by the simulations. That the discrete phospholipid sites detected
by NMR represent cation-p interactions is shown by measuring the binding
affinity for BtPI-PLC variants in which the unnatural amino acid 3,5-difluoro-
tyrosine has been site-specifically substituted for Tyr, thus reducing the
strength of cation-p interactions. These binding studies coupled with changes
in enzyme activity provide a detailed and quantitative picture of how PC inter-
actions with this PI-PLC influence its transient binding and cleavage of PI in
membranes.
1295-Pos Board B246
Membrane Interaction of Amyloid-Beta Peptide Induces Spontaneous
Membrane Invagination
Sha Jin1, Jo¨rg Nikolaus2, Andreas Herrmann2, Jan Bieschke3.
1Max Delbru¨ck Center for Molecular Medicine, Berlin, Germany, 2Biology,
Humboldt University, Berlin, Germany, 3Biomedical Engineering,
Washington University, Saint Louis, MO, USA.
One of the pathological hallmarks of Alzheimer’s disease (AD) is extracellular
plaques, in which the 42aa Amyloid beta peptide (Ab 1-42) is the main compo-
nent. Ab 1-42 is produced at cholesterol-rich regions of neuronal membranes
by endoproteolysis of the parental amyloid precursor protein and is secreted
into the extracellular space. Although Ab 1-42 accumulates extracellularly,
neurons internalize the Ab 1-42 peptide which could contribute to disease pro-
gression and which may be the first step to both cytotoxicity and propagation of
misfolded Ab between cells.
Interaction with membrane bilayer is likely the first step in the molecular mech-
anism of neuronal Ab 1-42 uptake. Therefore, we studied interaction of Ab
1-42 with the lipid bilayer in a giant unilamellar vesicles (GUVs) model sys-
tem. We found that the Ab 1-42 bound to the lipid bilayer and, after a lag phase
induced invagination of the membrane into small vesicular structures. Only
early oligomeric structures of Ab and stabilized the negative curvature of mem-
brane, whereas both monomeric and fibrillar forms of the peptide were unable
to induce or sustain membrane invagination.
Our results suggest that Ab may facilitate vesicle formation in lipid bilayer
membranes, which may be a factor in cellular Ab internalization but may
also hint at a possible physiological function of the Ab peptide at the synaptic
membrane.
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Amyloid formation in the pancreas by islet amyloid polypeptide (IAPP)
is closely associated with type-2 diabetes. Compelling evidence indicates
that membranes play a crucial role in contributing to IAPP amyloid for-
mation and that IAPP amyloid formation leads to cell membrane disruption
[1]. Since both IAPP amyloid formation and membrane damage are con-
sidered perilous to the pancreatic beta-cells, their inhibition may be an
effective strategy for the prevention and/ or treatment of the disease. Here,
we studied the interaction between a novel amyloid inhibitor ‘‘anle145c’’
[2] and IAPP in the absence and presence of model membranes. Our
results suggest that addition of anle145c to IAPP inhibits IAPP fibril
growth even at sub-stoichiometric concentrations, both in the absence and
presence of membranes. Anle145c also reduces membrane damage induced
by IAPP but does not induce membrane leakage by itself. Most notably,
anle145c shows a strong membrane interaction, resulting in a distinctly
different mode of inhibition than in the absence of membranes. We present
a model in which anle145c interacts with oligomeric IAPP species in solution,
but with monomeric or early oligomeric IAPP species in the presence of
membranes.
[1] Engel M et al., PNAS. (2008) - 105 :6033
[2] Wagner J et al., Acta Neuropathologica (2013) - 125: 795
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The hallmark characteristics of plaque formation and neuronal cell death in
Alzheimer’s disease (AD) are caused principally by the amyloid b-peptide
(Ab). Current research focuses on understanding the interactions between Ab
and neuronal cell membranes, given the relationship between membrane
perturbation and neurotoxicity. Ab sequence and lipid composition are essen-
tial variables to consider when elucidating the impact of the biological mem-
brane on Ab structure and the effect of Ab on membrane integrity. Atomistic
molecular dynamics simulations testing two Ab sequences (Human Ab1-42)
(HAb) and Rat Ab(1-42) (RAb)), five lipid types, and totaling 9 ms in simulation
time, were performed in order to explain the effect of these variables on mem-
brane perturbation. All metrics used to assess membrane perturbation agree in-
somuch that it can be concluded that HAb and RAb contribute to membrane
perturbation by causing a more rigid, gel-like lipid phase. The presence of
cholesterol in a model raft membrane was found to moderate the amount of
perturbation caused by HAb and RAb. Differences between HAb and RAb
were seen based on lipid headgroup charge and hydrogen bond capacity. The
position of arginine in the N-terminal region was determined to be the medi-
ating factor in these differences in lipid affinity and disruption between HAb
and RAb. Overall, this work rationalizes the influence of sequence and lipid
type on Ab-membrane interactions, providing mechanistic insight into the
etiology of AD.Membrane Receptors and Signal Transduction II
1298-Pos Board B249
Effect of Thanatophoric Dysplasia Type I Mutations on Fibroblast Growth
Factor Receptor 3 Dimerization
Nuala Del Piccolo, Kalina Hristova.
Materials Science & Engineering, Johns Hopkins University, Baltimore,
MD, USA.
Thanatophoric dysplasia type I (TDI) is a lethal human skeletal growth disorder
with a prevalence of 1 in 20,000 to 1 in 50,000 births. TDI is known to arise
due to five different mutations, all involving the substitution of an amino
acid with a cysteine in fibroblast growth factor receptor 3 (FGFR3). Cysteine
mutations in receptor tyrosine kinases have been previously proposed to induce
receptor cross-linking in the unliganded state, thus emulating the effect of
ligand and leading to receptor overactivation. Here, we characterize the effect
of three TDI mutations, Arg248Cys, Ser249Cys, and Tyr373Cys, on FGFR3
dimerization in mammalian membranes, in the absence of ligand. We demon-
strate that the mutations lead to modest stabilization and structural perturba-
tions of the FGFR3 dimers. Based on available FGFR crystal structures, we
argue that the effects of these mutations cannot emulate the effect of the ligand,
thus challenging the current understanding of the molecular interactions that
underlie TDI.
